📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
NEUTRAL
TOTAL VIEWS
27
AUTL Latest News & AI Sentiment Analysis
2 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 4 ARTICLES
Autolus Therapeutics plc 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:AUTL) 2026-08-11
AUTL published its Q2 2026 earnings call presentation on August 11, 2026. The disclosure is procedural in nature—a scheduled earnings...
Autolus Therapeutics plc (AUTL) Q2 2026 Earnings Call Transcript
AUTL released its Q2 2026 earnings call transcript, a scheduled procedural disclosure that provides management commentary on recent...
Autolus Therapeutics: Navigating A Bumpy 2026 (NASDAQ:AUTL)
Autolus Therapeutics (AUTL) is positioned as a clinical-stage biotech with meaningful near-term catalysts tied to its obe-cel CAR T-cell...
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Autolus Therapeutics (AUTL) disclosed routine equity compensation grants to 13 new employees under Nasdaq Rule 5635(c)(4), a standard...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice